These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 28234556)

  • 41. PMab-52: Specific and Sensitive Monoclonal Antibody Against Cat Podoplanin for Immunohistochemistry.
    Yamada S; Itai S; Nakamura T; Yanaka M; Saidoh N; Chang YW; Handa S; Harada H; Kagawa Y; Ichii O; Konnai S; Kaneko MK; Kato Y
    Monoclon Antib Immunodiagn Immunother; 2017 Oct; 36(5):224-230. PubMed ID: 28737447
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Characterization of anti-CD20 monoclonal antibody produced by transgenic silkworms (Bombyx mori).
    Tada M; Tatematsu K; Ishii-Watabe A; Harazono A; Takakura D; Hashii N; Sezutsu H; Kawasaki N
    MAbs; 2015; 7(6):1138-50. PubMed ID: 26261057
    [TBL] [Abstract][Full Text] [Related]  

  • 43. In vitro and in vivo activity of MT201, a fully human monoclonal antibody for pancarcinoma treatment.
    Naundorf S; Preithner S; Mayer P; Lippold S; Wolf A; Hanakam F; Fichtner I; Kufer P; Raum T; Riethmüller G; Baeuerle PA; Dreier T
    Int J Cancer; 2002 Jul; 100(1):101-10. PubMed ID: 12115595
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Expression of Cat Podoplanin in Feline Squamous Cell Carcinomas.
    Itai S; Yamada S; Kaneko MK; Harada H; Kagawa Y; Konnai S; Kato Y
    Monoclon Antib Immunodiagn Immunother; 2017 Dec; 36(6):243-250. PubMed ID: 29090969
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antipodoplanin antibody enhances the antitumor effects of CTLA-4 blockade against malignant mesothelioma by natural killer cells.
    Yoneda H; Mitsuhashi A; Yoshida A; Ogino H; Itakura S; Nguyen NT; Nokihara H; Sato S; Shinohara T; Hanibuchi M; Abe S; Kaneko MK; Kato Y; Nishioka Y
    Cancer Sci; 2024 Feb; 115(2):357-368. PubMed ID: 38148492
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Anti-CD44 Variant 10 Monoclonal Antibody Exerts Antitumor Activity in Mouse Xenograft Models of Oral Squamous Cell Carcinomas.
    Ishikawa K; Suzuki H; Ohishi T; Li G; Tanaka T; Kawada M; Ohkoshi A; Kaneko MK; Katori Y; Kato Y
    Int J Mol Sci; 2024 Aug; 25(17):. PubMed ID: 39273139
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inhibition of tumor cell-induced platelet aggregation using a novel anti-podoplanin antibody reacting with its platelet-aggregation-stimulating domain.
    Kato Y; Kaneko MK; Kuno A; Uchiyama N; Amano K; Chiba Y; Hasegawa Y; Hirabayashi J; Narimatsu H; Mishima K; Osawa M
    Biochem Biophys Res Commun; 2006 Nov; 349(4):1301-7. PubMed ID: 16979138
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mechanism of antitumor activity in mice for anti-epidermal growth factor receptor monoclonal antibodies with different isotypes.
    Masui H; Moroyama T; Mendelsohn J
    Cancer Res; 1986 Nov; 46(11):5592-8. PubMed ID: 3756906
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Detection of Tiger Podoplanin Using the Anti-Cat Podoplanin Monoclonal Antibody PMab-52.
    Yamada S; Itai S; Furusawa Y; Sano M; Nakamura T; Yanaka M; Handa S; Hisamatsu K; Nakamura Y; Fukui M; Harada H; Mizuno T; Sakai Y; Ogasawara S; Murata T; Uchida H; Tahara H; Kaneko MK; Kato Y
    Monoclon Antib Immunodiagn Immunother; 2018 Nov; 37(5):224-228. PubMed ID: 30362928
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Anti-β₂M monoclonal antibodies kill myeloma cells via cell- and complement-mediated cytotoxicity.
    Zhang M; Qian J; Lan Y; Lu Y; Li H; Hong B; Zheng Y; He J; Yang J; Yi Q
    Int J Cancer; 2014 Sep; 135(5):1132-41. PubMed ID: 24474467
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Establishment of Novel Monoclonal Antibody PMab-32 Against Rabbit Podoplanin.
    Honma R; Fujii Y; Ogasawara S; Oki H; Liu X; Nakamura T; Kaneko MK; Takagi M; Kato Y
    Monoclon Antib Immunodiagn Immunother; 2016 Feb; 35(1):41-7. PubMed ID: 26788987
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Functional characterization of recombinant snake venom rhodocytin: rhodocytin mutant blocks CLEC-2/podoplanin-dependent platelet aggregation and lung metastasis.
    Sasaki T; Shirai T; Tsukiji N; Otake S; Tamura S; Ichikawa J; Osada M; Satoh K; Ozaki Y; Suzuki-Inoue K
    J Thromb Haemost; 2018 May; 16(5):960-972. PubMed ID: 29488681
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Combination of two anti-CD5 monoclonal antibodies synergistically induces complement-dependent cytotoxicity of chronic lymphocytic leukaemia cells.
    Klitgaard JL; Koefoed K; Geisler C; Gadeberg OV; Frank DA; Petersen J; Jurlander J; Pedersen MW
    Br J Haematol; 2013 Oct; 163(2):182-93. PubMed ID: 23927424
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Epidermal growth factor receptor (EGFR) antibody-induced antibody-dependent cellular cytotoxicity plays a prominent role in inhibiting tumorigenesis, even of tumor cells insensitive to EGFR signaling inhibition.
    Overdijk MB; Verploegen S; van den Brakel JH; Lammerts van Bueren JJ; Vink T; van de Winkel JG; Parren PW; Bleeker WK
    J Immunol; 2011 Sep; 187(6):3383-90. PubMed ID: 21832160
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Targeting C-type lectin-like molecule-1 for antibody-mediated immunotherapy in acute myeloid leukemia.
    Zhao X; Singh S; Pardoux C; Zhao J; Hsi ED; Abo A; Korver W
    Haematologica; 2010 Jan; 95(1):71-8. PubMed ID: 19648166
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antibody and lectin target podoplanin to inhibit oral squamous carcinoma cell migration and viability by distinct mechanisms.
    Ochoa-Alvarez JA; Krishnan H; Pastorino JG; Nevel E; Kephart D; Lee JJ; Retzbach EP; Shen Y; Fatahzadeh M; Baredes S; Kalyoussef E; Honma M; Adelson ME; Kaneko MK; Kato Y; Young MA; Deluca-Rapone L; Shienbaum AJ; Yin K; Jensen LD; Goldberg GS
    Oncotarget; 2015 Apr; 6(11):9045-60. PubMed ID: 25826087
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Immunohistochemical Detection of Sheep Podoplanin Using an Antibovine Podoplanin Monoclonal Antibody PMab-44.
    Kato Y; Yamada S; Itai S; Kobayashi A; Konnai S; Kaneko MK
    Monoclon Antib Immunodiagn Immunother; 2018 Dec; 37(6):265-268. PubMed ID: 30570359
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Defucosylated mouse‑dog chimeric anti‑HER2 monoclonal antibody exerts antitumor activities in mouse xenograft models of canine tumors.
    Suzuki H; Ohishi T; Asano T; Tanaka T; Saito M; Mizuno T; Yoshikawa T; Kawada M; Kaneko MK; Kato Y
    Oncol Rep; 2022 Sep; 48(3):. PubMed ID: 35856438
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A novel anti-human HB-EGF monoclonal antibody with multiple antitumor mechanisms against ovarian cancer cells.
    Miyamoto S; Iwamoto R; Furuya A; Takahashi K; Sasaki Y; Ando H; Yotsumoto F; Yoneda T; Hamaoka M; Yagi H; Murakami T; Hori S; Shitara K; Mekada E
    Clin Cancer Res; 2011 Nov; 17(21):6733-41. PubMed ID: 21918176
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Generation and characterization of a target-selectively activated antibody against epidermal growth factor receptor with enhanced anti-tumor potency.
    Yang Y; Guo Q; Xia M; Li Y; Peng X; Liu T; Tong X; Xu J; Guo H; Qian W; Hou S; Dai J; Wang H; Liu R; Guo Y
    MAbs; 2015; 7(2):440-50. PubMed ID: 25679409
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.